December 13, 2023 11:12 AM EST

Sofinnova details European investment strategy; C4's new PhI data; Coya closes $26M placement

Jaimy Lee

Deputy Editor

Kyle LaHucik

Senior Reporter

Sofinnova Partners outlines European investment strategy: The venture capital firm aims to launch and accelerate biotech startups in Europe using a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sofinnova details European investment strategy; C4's new PhI data; Coya closes $26M placement

Jaimy Lee

Deputy Editor

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Patient dies in Neurogene's Rett syndrome study

Are programs with compounded GLP-1s safe for your population?

Sofinno­va de­tails Eu­ro­pean in­vest­ment strat­e­gy; C4's new PhI da­ta; Coya clos­es $26M place­ment

Deputy Editor

Senior Reporter

Sign up to read this article for free.

Sofinnova details European investment strategy; C4's new PhI data; Coya closes $26M placement